SEC Form 4 · accession 0001140361-16-056448
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Happel
Officer — Chief Commerical Officer
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 7:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2016 | F | 576 | $3.433 | D | 29,670 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by Raptor to satisfy tax withholding obligations applicable to vesting of 1,307 stock-settled restricted stock units.